ArticleNature communications2026
Molecular mapping in DNA-PAINT via modified Gaussian Mixture Modeling.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Simulating Multicolor Super-Resolution Imaging Using an RGB Camera.Computational and structural biotechnology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Super-resolution fluorescence microscopy, and specifically DNA-PAINT, provides localization precision down to ~2 nm enabling molecular-resolution imaging. To produce molecular maps of single biomolecules, their positions must be inferred from localizations stemming from single fluorescent molecules. Current clustering methods fail to exploit the full potential of the imaging method. Here, we introduce G5M, a modified Gaussian Mixture Modeling algorithm tailored to DNA-PAINT data. By incorporating prior knowledge of localization precision, spatial constraints, and DNA hybridization kinetics, G5M accurately infers true molecular positions while avoiding overfitting. In realistic simulations of dimers, G5M resolves molecules at the Rayleigh limit with a 27-fold higher recovery rate than current methods and <0.1% false positives. Applied to experimental datasets, G5M recovers full nuclear pore complex structures and detects higher-order CD20 oligomers induced by antibody treatment, outperforming conventional DNA-PAINT analysis. G5M is implemented in the open-source Picasso platform, offering an accessible solution for high-resolution, high-accuracy molecular mapping in super-resolution microscopy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.